Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 1, Pages 74
Publisher
MDPI AG
Online
2019-01-22
DOI
10.3390/cells8010074
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
- (2018) Sifeng Qu et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer
- (2018) Xinpei Ci et al. CANCER RESEARCH
- Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer
- (2018) Hiroshi Hongo et al. CANCER SCIENCE
- Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine
- (2018) Seiji Okada et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
- (2018) Jun Hao et al. EUROPEAN UROLOGY
- Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
- (2018) Hendrik Borgmann et al. EUROPEAN UROLOGY
- Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
- (2018) Fan Mo et al. EUROPEAN UROLOGY
- Patient derived organoids to model rare prostate cancer phenotypes
- (2018) Loredana Puca et al. Nature Communications
- Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines
- (2018) Kazuaki Machioka et al. Oncotarget
- Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
- (2018) Mitchell G. Lawrence et al. EUROPEAN UROLOGY
- Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models
- (2018) Nora M. Navone et al. PROSTATE
- A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer
- (2018) Woong Sub Byun et al. BIOCHEMICAL PHARMACOLOGY
- Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer
- (2018) Johannes Linxweiler et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
- (2018) Martin K Bakht et al. ENDOCRINE-RELATED CANCER
- Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
- (2017) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells
- (2017) Joshua J. Souchek et al. MOLECULAR CANCER THERAPEUTICS
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models
- (2017) Leanne Woods-Burnham et al. PROSTATE
- Modeling Development and Disease with Organoids
- (2016) Hans Clevers CELL
- Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
- (2016) Hung-Ming Lam et al. CLINICAL CANCER RESEARCH
- Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer
- (2016) X. Chen et al. CLINICAL CANCER RESEARCH
- Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas
- (2016) Brittany Kleb et al. Epigenetics
- Downregulation of cytokeratin 18 is associated with paclitaxel-resistance and tumor aggressiveness in prostate cancer
- (2016) BO YIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Androgen-induced Long Noncoding RNA (lncRNA)SOCS2-AS1Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells
- (2016) Aya Misawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- US cancer institute to overhaul tumour cell lines
- (2016) Heidi Ledford NATURE
- Organoid culture systems for prostate epithelial and cancer tissue
- (2016) Jarno Drost et al. Nature Protocols
- Skp2 is associated with paclitaxel resistance in prostate cancer cells
- (2016) YEGUO YANG et al. ONCOLOGY REPORTS
- Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer
- (2016) Shifeng Su et al. PROSTATE
- Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model
- (2016) Elizabeth M. Masko et al. PROSTATE
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
- (2016) Tatsuo Sugawara et al. Oncotarget
- Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity
- (2015) T. Ishiguro et al. CANCER RESEARCH
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Organoid development in cancer genome discovery
- (2015) Dong Gao et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
- (2015) Zhi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer
- (2015) Mitchell G. Lawrence et al. PROSTATE
- TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
- (2015) Ken-ichi Takayama et al. Nature Communications
- Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy
- (2015) Daniel O’Neill et al. Oncotarget
- PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
- (2015) Adeodat Ilboudo et al. International Journal of Environmental Research and Public Health
- Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
- (2014) Maria Thadani-Mulero et al. CANCER RESEARCH
- Cancer Cell Lines for Drug Discovery and Development
- (2014) J. L. Wilding et al. CANCER RESEARCH
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer
- (2014) T. Lange et al. CLINICAL CANCER RESEARCH
- Establishment and Characterization of a Highly Tumorigenic African American Prostate Cancer Cell Line, E006AA-hT
- (2014) Shahriar Koochekpour et al. International Journal of Biological Sciences
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment
- (2014) Yu-Chen Lee et al. MOLECULAR & CELLULAR PROTEOMICS
- Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening
- (2014) Eliza L. S. Fong et al. MOLECULAR PHARMACEUTICS
- Genome sequencing of normal cells reveals developmental lineages and mutational processes
- (2014) Sam Behjati et al. NATURE
- Targeting Poly(ADP-Ribose) Polymerase and the c-Myb-Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
- (2014) L. Li et al. Science Signaling
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
- (2013) Taku Kato et al. CYTOKINE
- Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer
- (2013) Ken-ichi Takayama et al. EMBO JOURNAL
- The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment
- (2013) Chika Iwamoto et al. EXPERIMENTAL HEMATOLOGY
- A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
- (2013) H. Kuruma et al. MOLECULAR CANCER THERAPEUTICS
- A preclinical xenograft model of prostate cancer using human tumors
- (2013) Mitchell G Lawrence et al. Nature Protocols
- Ex vivo culture of human prostate tissue and drug development
- (2013) Margaret M. Centenera et al. Nature Reviews Urology
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
- (2012) Tobias Lange et al. CLINICAL CANCER RESEARCH
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer
- (2012) John J. Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- TACC2 Is an Androgen-Responsive Cell Cycle Regulator Promoting Androgen-Mediated and Castration-Resistant Growth of Prostate Cancer
- (2012) Ken-ichi Takayama et al. MOLECULAR ENDOCRINOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
- (2012) Y Li et al. ONCOGENE
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
- (2012) Saurabh Singh et al. PLoS One
- ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
- (2011) Taku Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
- (2011) Y. Li et al. CANCER RESEARCH
- Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
- (2011) V. Tzelepi et al. CLINICAL CANCER RESEARCH
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells
- (2011) Youqiang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines
- (2011) Rute B. Marques et al. PLoS One
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Brief Report: A Bioassay to Identify Primary Human Prostate Cancer Repopulating Cells
- (2011) Roxanne Toivanen et al. STEM CELLS
- Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer
- (2011) Feng Li et al. Drug Delivery and Translational Research
- Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
- (2010) N. Terada et al. CANCER RESEARCH
- Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation
- (2010) S. Marchiani et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles
- (2010) Ana Aparicio et al. PROSTATE
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- Expression of HLA-like structures on a permanent human tumor line PC-93
- (2010) Frans H. J. Claas et al. TISSUE ANTIGENS
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
- Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft
- (2009) Naoki Terada et al. PROSTATE
- CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer
- (2009) YouQiang Li et al. PROSTATE
- Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy
- (2008) Richard D. Sowery et al. BJU INTERNATIONAL
- Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
- (2008) W M van Weerden et al. BRITISH JOURNAL OF CANCER
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers
- (2008) Rochelle A. Simon et al. HUMAN PATHOLOGY
- Androgen receptor–negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
- (2008) Zhi Gang Li et al. JOURNAL OF CLINICAL INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started